Sowell Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-16,593
Closed -$344K – 1043
2025
Q1
$344K Buy
+16,593
New +$417K 0.02% 709
2023
Q3
– Sell
-10,585
Closed -$361K – 509
2023
Q2
$361K Buy
10,585
+225
+2% +$7.07K 0.02% 493
2023
Q1
$312K Buy
+10,360
New +$321K 0.02% 542
2021
Q2
– Sell
-7,001
Closed -$559K – 654
2021
Q1
$559K Buy
7,001
+1,617
+30% +$160K 0.02% 604
2020
Q4
$502K Buy
5,384
+1,849
+52% +$147K 0.02% 525
2020
Q3
$225K Buy
3,535
+612
+21% +$35.9K 0.01% 690
2020
Q2
$152K Buy
2,923
+130
+5% +$5.58K 0.01% 819
2020
Q1
$87K Buy
2,793
+253
+10% +$8.45K 0.01% 889
2019
Q4
$85K Hold
2,540
– – 0.01% 965
2019
Q3
$75K Buy
+2,540
New +$82.6K 0.01% 894

Other funds holding ARKG

Sowell Financial Services's ARKG Position: Q2 2025 in Review

Sowell Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 16,593 shares — an estimated $344K sold.

Sowell Financial Services first reported a position in ARKG in Q3 2019 and held it in 10 quarters. The position peaked at $559K in Q1 2021. 216 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

  • Sowell Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
  • Sowell Financial Services sold 16,593 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $344K.
  • Sowell Financial Services first reported a position in ARK Genomic Revolution ETF in Q3 2019 and held it in 10 quarters.
  • Sowell Financial Services's ARK Genomic Revolution ETF position peaked at $559K in Q1 2021.
  • 216 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Sowell Financial Services's 13F filing for Q2 2025, filed 14 Jul 2025.